OC-2024-123261-task order for move and labor services - headquarters consolidation project: move management and move units.
Ended Awarded Last action
- Contract number
- 75F40124F19020
- Awardee
-
Elocen Global Technology, LLC UEI SPBXSNXM3S17
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $885,480
Award facts
- Contract value 100% obligated
- $885,480.40 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 484210 Used Household and Office Goods Moving
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lanham, MD 20706, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $885,480 |
About this award
The Food and Drug Administration awarded a $885,480.40 firm fixed-price delivery order to Elocen Global Technology, LLC for move and labor services supporting the agency's headquarters consolidation project. This competitive 8(a) set-aside contract, issued on September 9, 2024, encompasses move management and move unit services with an ultimate completion date of November 15, 2025. The work will be performed in Lanham, Maryland, where the awardee maintains its principal operations. Elocen Global Technology is a minority-owned, small disadvantaged, woman-owned, and service-disabled veteran-owned small business that has established a substantial track record with the FDA across multiple service categories.
This delivery order is issued under Elocen Global Technology's existing $50 million 8(a) indefinite delivery/indefinite quantity contract vehicle with the FDA. The contractor has consistently executed similar move management, warehouse operations, and facilities support services for the agency without utilizing subcontractors. The headquarters consolidation project represents a continuation of the company's core competencies in managing complex logistical operations across FDA facilities, positioning the contractor to leverage existing operational knowledge and infrastructure to execute the required move management and labor services efficiently through the stated completion deadline.
Quick answers
Who was awarded contract 75F40124F19020?
75F40124F19020 was awarded to Elocen Global Technology, LLC by Food and Drug Administration (Department of Health and Human Services) on September 9, 2024.
How much is contract 75F40124F19020 worth?
The government has obligated $885,480 on 75F40124F19020.
Is contract 75F40124F19020 an order under another contract?
Yes. 75F40124F19020 is a delivery order under 75F40119D10019, an indefinite delivery contract.
Was contract 75F40124F19020 competed?
The extent of competition for 75F40124F19020 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award